Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_27310 | 77 | 1.61 | Mlig455_002362 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.676 Region-enriched R2: 3.917/0.01447 |
Mlig455_002362 {REF} {Length: 2243} {RNA1310_27036} {RNA815_28595} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.623 | 1.665 | 1.00000 | 1.00000 | |
RegionR2 | 3.917 | 1.665 | 0.00056 | 0.01447 | |
RegionR3 | 1.176 | 1.665 | 0.24983 | 0.79368 | |
RegionR4 | -0.184 | 1.665 | 0.73562 | 1.00000 | |
RegionR5 | -0.364 | 1.665 | 0.80722 | 1.00000 | |
RegionR6 | -3.476 | 1.665 | 0.99977 | 1.00000 | |
RegionR7 | 1.136 | 1.665 | 0.38266 | 1.00000 | |
RegionR8 | 1.416 | 1.665 | 0.39228 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.666 | 1.665 | 0.99996 | 1.00000 | |
RegenerationR2 | -0.773 | 1.665 | 0.26631 | 0.71233 | |
RegenerationR3 | -0.961 | 1.665 | 0.36380 | 0.77974 | |
RegenerationR4 | -0.791 | 1.665 | 0.50108 | 0.87015 | |
RegenerationR5 | -2.958 | 1.665 | 0.03566 | 0.31356 | |
RegenerationR6 | 3.495 | 1.665 | 0.05328 | 0.28915 | |
RegenerationBL | -0.542 | 1.665 | 0.78268 | 1.00000 | |
RegenerationTP | 1.425 | 1.665 | 0.28473 | 0.73153 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_27310 | 77 | 1.61 | Mlig455_002362 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.676 Region-enriched R2: 3.917/0.01447 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_002362 {REF} {Length: 2243} {RNA1310_27036} {RNA815_28595} | |
2. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
4.563 | 0.963 | 0.920 | 0.923 | 0.843 | - | 0.914 | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
3. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
4.517 | 0.857 | 0.935 | 0.910 | 0.836 | - | 0.979 | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
4. | MligTC455_13376 | 101 | 2.1 | Mlig455_040613 | Neo: - Age: - Region-specific R2: 4.973 Region-enriched R2: 6.158/0.00016 |
4.462 | 0.861 | 0.965 | 0.850 | 0.868 | - | 0.918 | Mlig455_040613 {REF} {Length: 2807} {RNA1310_27894} {RNA815_60961} | |
5. | MligTC455_24952 | 637 | 13.28 | Mlig455_054178, Mlig455_060727 | Neo: - Age: Down-Up-Down Region-specific R2: 4.165 Region-enriched R2: 3.160/0.00003 Regeneration-downregulated BL: -4.774 Regeneration-depleted BL: -4.774 |
CCDC169 | 4.419 | 0.837 | 0.956 | 0.853 | 0.877 | - | 0.896 | Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545} |
6. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 4.381 | 0.836 | 0.910 | 0.872 | 0.803 | - | 0.960 | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
7. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 4.38 | 0.804 | 0.955 | 0.837 | 0.828 | - | 0.956 | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
8. | MligTC455_29315 | 105 | 2.19 | Mlig455_041530, Mlig455_069393 | Neo: - Age: logFC(26M/2M)=1.756 |
4.324 | 0.913 | - | 0.975 | 0.828 | 0.729 | 0.879 | Mlig455_041530 {REF} {Length: 2302} {RNA1310_27036} {RNA815_28595} Mlig455_069393 {REF} {Length: 1213} {RNA1310_27036} {RNA815_28595} |
|
9. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
4.297 | 0.785 | 0.845 | 0.909 | 0.781 | - | 0.977 | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
10. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 4.27 | 0.848 | 0.949 | 0.744 | 0.752 | - | 0.977 | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
11. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 4.255 | 0.741 | 0.851 | 0.909 | 0.791 | - | 0.963 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
12. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 4.17 | 0.741 | 0.851 | 0.817 | 0.797 | - | 0.964 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
13. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
4.145 | 0.710 | 0.923 | 0.738 | 0.799 | - | 0.975 | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
14. | MligTC455_37988 | 67 | 1.41 | Mlig455_008561 | Neo: - Age: - Region-enriched R2: 8.988/0.00000 |
4.101 | 0.858 | 0.954 | 0.772 | 0.786 | 0.731 | - | Mlig455_008561 {REF} {Length: 3146} {Pfam: EF-hand domain pair [PF13499.8, score=36.5]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.4]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=104, Expect=1e-26]} {RNA1310_31713.1} {RNA815_36423} | |
15. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 3.663 | - | 0.882 | 0.942 | 0.880 | - | 0.959 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
16. | MligTC455_17138 | 283 | 5.89 | Mlig455_029728 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.646 Region-specific R2: 4.824 Region-enriched R2: 5.583/0.00000 |
LRRCC1 | 3.62 | - | 0.951 | 0.947 | 0.773 | - | 0.949 | Mlig455_029728 {REF} {Length: 1372} {Pfam: Heat shock factor binding protein 1 [PF06825.14, score=68.1]; Leucine Rich repeats (2 copies) [PF12799.9, score=67.8]; Leucine rich repeat [PF13855.8, score=44.9]; Leucine-rich repeat [PF14580.8, score=35.0]; Leucine Rich repeat [PF13516.8, score=21.5]} {Human: ENSG00000133739, LRRCC1, leucine rich repeat and coiled-coil centrosomal protein 1, [RH, Score=402, Expect=3e-122]} {Mouse: ENSMUSG00000027550, Lrrcc1, leucine rich repeat and coiled-coil domain containing 1, [RH, Score=387, Expect=3e-117]} {Dmel: FBgn0032429, CG5446, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00189952, K10D2.8, [Score=65.1, Expect=8e-11]} {Smed: dd_Smed_v6_10086_0_1, dd_Smed_v6_10086_0_1, [RH, Score=443, Expect=2e-139]} {RNA1509_31405, RNA1509_32465} {RNA1310_70756, RNA1509_31405, RNA1509_32465} {RNA1509_31405, RNA1509_32465, RNA815_37567} |
17. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
3.592 | 0.869 | - | 0.867 | 0.902 | - | 0.954 | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
18. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 3.556 | 0.822 | 0.842 | 0.923 | - | - | 0.969 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
19. | MligTC455_41028 | 108 | 2.26 | Mlig455_033278 | Neo: - Age: - |
3.538 | 0.872 | - | 0.961 | 0.737 | - | 0.968 | Mlig455_033278 {REF} {Length: 1134} {Pfam: PAN domain [PF00024.28, score=19.4]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=9e-14]} {RNA1310_31986} {RNA815_17816.2} | |
20. | MligTC455_44195 | 267 | 5.56 | Mlig455_057666 | Neo: - Age: logFC(26M/2M)=0.586 Region-enriched R2: 4.885/0.00002 |
3.504 | 0.756 | 0.947 | 0.830 | - | - | 0.971 | Mlig455_057666 {REF} {Length: 1757} {RNA1509_45654, RNA1509_50922} {RNA1310_26801.2, RNA1509_45654, RNA1509_50922} {RNA1509_45654, RNA1509_50922, RNA815_13136} | |
21. | MligTC455_19524 | 100 | 2.09 | Mlig455_010263 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.437/0.01311 |
3.497 | 0.802 | - | 0.903 | 0.821 | - | 0.971 | Mlig455_010263 {REF} {Length: 2969} {RNA1310_11925.1} {RNA815_27110} | |
22. | MligTC455_40289 | 93 | 1.94 | Mlig455_017727, Mlig455_056175 | Neo: - Age: - |
BMP1, CUBN | 3.493 | 0.976 | - | 0.835 | 0.758 | - | 0.924 | Mlig455_017727 {REF} {Length: 1202} {Pfam: CUB domain [PF00431.22, score=55.3]} {Human: ENSG00000107611, CUBN, cubilin, [Score=54.7, Expect=4e-08]; ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=52.0, Expect=3e-07]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=51.6, Expect=3e-07]; ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=49.7, Expect=1e-06]} {Dmel: FBgn0003719, tld, tolloid, [Score=51.2, Expect=3e-07]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=47.4, Expect=2e-07]} {RNA1310_48745} {RNA815_23305} Mlig455_056175 {REF} {Length: 2747} {Pfam: CUB domain [PF00431.22, score=62.6]} {Human: ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=52.8, Expect=2e-07]; ENSG00000107611, CUBN, cubilin, [Score=51.6, Expect=4e-07]} {Mouse: ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=51.6, Expect=3e-07]; ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=49.7, Expect=1e-06]} {Dmel: FBgn0003719, tld, tolloid, [Score=51.2, Expect=3e-07]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=47.0, Expect=3e-07]} {RNA1310_48745} {RNA815_23305} |
23. | MligTC455_47261 | 1918 | 39.96 | Mlig455_033946 | Neo: - Age: - Region-specific R2: 4.808 Region-enriched R2: 4.545/0.00000 |
3.477 | - | 0.827 | 0.808 | 0.876 | - | 0.966 | Mlig455_033946 {REF} {Length: 2098} {RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1310_36725.1, RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1509_18239, RNA1509_26992, RNA1509_32368, RNA815_10268.1} | |
24. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
3.459 | 0.868 | 0.779 | 0.835 | - | - | 0.977 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
25. | MligTC455_16749 | 454 | 9.45 | Mlig455_001550, Mlig455_046548 | Neo: - Age: logFC(26M/2M)=0.515 Region-specific R2: 4.360 Region-enriched R2: 3.409/0.00015 |
TRAF4 | 3.454 | 0.949 | 0.796 | 0.757 | - | - | 0.952 | Mlig455_001550 {REF} {Length: 4563} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=237, Expect=4e-72]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=241, Expect=7e-74]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=1e-44]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=276, Expect=1e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813, RNA1509_20900} {RNA1509_20900, RNA815_2335.1} Mlig455_046548 {REF} {Length: 3881} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=236, Expect=1e-71]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=240, Expect=3e-73]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=9e-45]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=275, Expect=6e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813} {RNA815_2335.1} |
26. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
3.448 | 0.800 | - | 0.859 | 0.822 | - | 0.967 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
27. | MligTC455_35258 | 2779 | 57.89 | Mlig455_040964 | Neo: - Age: Up-Down-Down Region-specific R2: 2.469 Region-enriched R2: 1.501/0.00133 |
3.43 | - | 0.883 | 0.817 | 0.753 | - | 0.977 | Mlig455_040964 {REF} {Length: 8259} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=543, Expect=9e-160]} {RNA1509_16633, RNA1509_52679} {RNA1310_236.2, RNA1509_16633} {RNA1509_16633, RNA815_77.1} | |
28. | MligTC455_24536 | 120 | 2.5 | Mlig455_028895 | Neo: - Age: Up-Down-Down |
TRPA1 | 3.4 | 0.805 | - | 0.835 | 0.796 | - | 0.964 | Mlig455_028895 {REF} {Length: 4399} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.9]; Ankyrin repeats (many copies) [PF13637.8, score=235.5]; Ankyrin repeats (many copies) [PF13857.8, score=187.3]; Ankyrin repeat [PF00023.32, score=185.3]; Ankyrin repeat [PF13606.8, score=184.2]; Ion transport protein [PF00520.33, score=31.3]} {Human: ENSG00000104321, TRPA1, transient receptor potential cation channel subfamily A member 1, [Score=295, Expect=6e-83]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=277, Expect=4e-77]} {Dmel: FBgn0035934, TrpA1, Transient receptor potential cation channel A1, [Score=305, Expect=2e-86]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=276, Expect=1e-76]} {Smed: dd_Smed_v6_20683_0_1, dd_Smed_v6_20683_0_1, [RH, Score=551, Expect=2e-178]} {RNA1509_56559} {RNA1310_3837.1} {RNA815_4441} |
29. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 3.391 | 0.784 | - | 0.810 | 0.830 | - | 0.967 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
30. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
3.385 | 0.841 | - | 0.827 | 0.740 | - | 0.977 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
31. | MligTC455_30620 | 201 | 4.18 | Mlig455_058938 | Neo: - |
3.38 | - | 0.784 | 0.762 | - | 0.882 | 0.952 | Mlig455_058938 {REF} {Length: 4222} {Pfam: Mab-21 protein [PF03281.16, score=39.0]} {RNA1509_51832, RNA1509_59365} {RNA1310_6164, RNA1509_59365} {RNA1509_59365, RNA815_1489.1} | |
32. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 3.373 | - | 0.847 | 0.781 | 0.783 | - | 0.962 | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
33. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 3.371 | - | 0.954 | 0.708 | 0.733 | - | 0.976 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
34. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
3.366 | 0.855 | 0.959 | 0.795 | 0.757 | - | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
35. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 3.348 | 0.703 | 0.899 | - | 0.764 | - | 0.982 | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
36. | MligTC455_21668 | 84 | 1.74 | Mlig455_024837 | Neo: - |
PPP3R1 | 3.342 | 0.821 | 0.963 | 0.840 | 0.718 | - | - | Mlig455_024837 {REF} {Length: 1650} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613} {RNA1310_16848.1} {RNA815_6272} |
37. | MligTC455_53504 | 217 | 4.51 | Mlig455_037385 | Neo: - Age: - Region-enriched R2: 3.142/0.00738 |
CSMD1 | 3.322 | 0.801 | - | 0.706 | 0.859 | - | 0.956 | Mlig455_037385 {REF} {Length: 2214} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=198.7]} {Human: ENSG00000183117, CSMD1, CUB and Sushi multiple domains 1, [Score=149, Expect=8e-37]} {Mouse: ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=136, Expect=7e-33]; ENSMUSG00000060924, Csmd1, CUB and Sushi multiple domains 1, [Score=134, Expect=5e-32]; ENSMUSG00000022311, Csmd3, CUB and Sushi multiple domains 3, [Score=133, Expect=9e-32]} {Dmel: FBgn0032797, Hasp, Hig-anchoring scaffold protein, [RH, Score=218, Expect=3e-60]} {Celegans: WBGene00002976, lev-9, [RH, Score=244, Expect=4e-72]} {Smed: dd_Smed_v6_13071_0_1, dd_Smed_v6_13071_0_1, [RH, Score=296, Expect=1e-91]} {RNA1509_55985} {RNA1310_12867.1, RNA1509_55985} {RNA1509_55985, RNA815_9157} |
38. | MligTC455_54019 | 59 | 1.23 | Mlig455_050979 | Neo: - Age: logFC(26M/2M)=0.902 |
DEGS2 | 3.319 | 0.816 | 0.768 | - | 0.762 | - | 0.973 | Mlig455_050979 {REF} {Length: 2343} {Pfam: Fatty acid desaturase [PF00487.26, score=84.5]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=59.9]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=332, Expect=1e-111]} {Mouse: ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=320, Expect=3e-107]; ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=304, Expect=8e-101]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=354, Expect=1e-120]} {Celegans: WBGene00013197, ttm-5, Putative sphingolipid delta(4)-desaturase/C4-monooxygenase, [Score=325, Expect=1e-108]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=422, Expect=6e-147]} {RNA1509_11966, RNA1509_33417, RNA1509_59878} {RNA1310_11518, RNA1509_11966, RNA1509_33417, RNA1509_59878} {RNA1509_11966, RNA1509_33417, RNA1509_59878, RNA815_6718} |
39. | MligTC455_22973 | 69 | 1.43 | Mlig455_035875, Mlig455_035912, Mlig455_035913 | Neo: - Age: - |
3.299 | - | 0.952 | 0.712 | - | 0.739 | 0.896 | Mlig455_035875 {REF} {Length: 3712} {NoTransDecoderORF} {RNA1310_130183} {RNA815_30776} Mlig455_035912 {REF} {Length: 1408} {NoTransDecoderORF} {RNA1310_102146} {RNA815_30776} Mlig455_035913 {REF} {Length: 776} {NoTransDecoderORF} {RNA1310_29036.3} |
|
40. | MligTC455_26092 | 67 | 1.39 | Mlig455_048489 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.677 Region-enriched R2: 4.303/0.01110 |
3.284 | - | 0.787 | 0.728 | 0.809 | - | 0.960 | Mlig455_048489 {REF} {Length: 2319} {Pfam: Lectin C-type domain [PF00059.23, score=23.3]} {RNA1509_25383} {RNA1310_27113} {RNA815_24719} | |
41. | MligTC455_40119 | 114 | 2.37 | Mlig455_034596 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.158/0.00258 |
KCNIP1 | 3.272 | 0.802 | - | 0.794 | 0.711 | - | 0.965 | Mlig455_034596 {REF} {Length: 1987} {Pfam: EF-hand domain pair [PF13499.8, score=42.4]; EF hand [PF00036.34, score=38.6]; EF-hand domain [PF13405.8, score=33.5]; EF hand [PF13202.8, score=31.2]; EF-hand domain pair [PF13833.8, score=28.7]} {Human: ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=122, Expect=3e-32]; ENSG00000185774, KCNIP4, potassium voltage-gated channel interacting protein 4, [Score=122, Expect=2e-32]; ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=119, Expect=1e-30]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=124, Expect=5e-33]; ENSMUSG00000029088, Kcnip4, Kv channel interacting protein 4, [Score=122, Expect=1e-32]} {Dmel: FBgn0013303, Nca, Neurocalcin, [Score=100, Expect=6e-25]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=103, Expect=6e-26]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=122, Expect=7e-33]} {RNA1310_43225} {RNA815_33406} |
42. | MligTC455_16199 | 114 | 2.37 | Mlig455_041013, Mlig455_041178 | Neo: Irradiation Age: - Region-enriched R2: 9.007/0.00037 |
3.201 | 0.743 | 0.964 | 0.747 | 0.747 | - | - | Mlig455_041013 {REF} {Length: 3381} {RNA1509_42904} {RNA1310_20434} {RNA815_22064} Mlig455_041178 {REF} {Length: 2722} {RNA1509_42904} {RNA1310_20004} {RNA815_22064} |
|
43. | MligTC455_42037 | 1931 | 40.23 | Mlig455_063391 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.444 Region-specific R2: 2.479 Region-enriched R2: 1.442/0.00136 |
3.162 | - | 0.704 | 0.770 | 0.725 | - | 0.963 | Mlig455_063391 {REF} {Length: 1482} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1310_24553, RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236, RNA815_11766} | |
44. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
2.788 | - | - | 0.954 | 0.857 | - | 0.977 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
45. | MligTC455_41036 | 281 | 5.86 | Mlig455_057198 | Neo: - Age: - Region-specific R2: 5.284 Region-enriched R2: 4.243/0.00075 |
2.778 | - | - | 0.962 | - | 0.827 | 0.989 | Mlig455_057198 {REF} {Length: 538} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.9]} {RNA1509_42071} {RNA1310_74103, RNA1509_42071} {RNA1509_42071, RNA815_38377} | |
46. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 2.777 | - | 0.963 | 0.869 | - | - | 0.945 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
47. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 2.773 | - | 0.915 | 0.886 | - | - | 0.972 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
48. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
2.763 | 0.854 | - | 0.937 | - | - | 0.972 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
49. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 2.733 | 0.868 | - | 0.893 | - | - | 0.972 | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
50. | MligTC455_50464 | 64 | 1.34 | Mlig455_007906, Mlig455_008010 | Neo: - Age: - |
2.732 | - | 0.863 | - | 0.892 | - | 0.977 | Mlig455_007906 {REF} {Length: 3294} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} Mlig455_008010 {REF} {Length: 1139} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} |
|
51. | MligTC455_43741 | 196 | 4.08 | Mlig455_018088 | Neo: - Age: Down-Up-Down |
PTBP1 | 2.731 | 0.794 | 0.945 | - | - | - | 0.992 | Mlig455_018088 {REF} {Length: 2775} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=116.9]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=52.7]; Occluded RNA-recognition motif [PF16842.7, score=26.8]} {Human: ENSG00000011304, PTBP1, polypyrimidine tract binding protein 1, [Score=258, Expect=8e-80]; ENSG00000117569, PTBP2, polypyrimidine tract binding protein 2, [Score=258, Expect=1e-80]; ENSG00000119314, PTBP3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-76]} {Mouse: ENSMUSG00000028134, Ptbp2, polypyrimidine tract binding protein 2, [Score=258, Expect=7e-81]; ENSMUSG00000006498, Ptbp1, polypyrimidine tract binding protein 1, [Score=251, Expect=1e-78]; ENSMUSG00000028382, Ptbp3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-77]} {Dmel: FBgn0011224, heph, hephaestus, [Score=249, Expect=7e-78]} {Celegans: WBGene00004207, ptb-1, PTB (HnRNP) homolog; Putative RNA-binding protein PTB-1b, [Score=234, Expect=1e-72]} {Smed: dd_Smed_v6_1868_0_1, dd_Smed_v6_1868_0_1, [Score=214, Expect=4e-64]} {RNA1509_36451} {RNA1310_3345} {RNA815_23519} |
52. | MligTC455_53295 | 119 | 2.48 | Mlig455_060263 | Neo: - Age: - |
LMO4 | 2.721 | 0.930 | - | 0.803 | - | - | 0.988 | Mlig455_060263 {REF} {Length: 1717} {Pfam: LIM domain [PF00412.24, score=87.3]} {Human: ENSG00000143013, LMO4, LIM domain only 4, [Score=133, Expect=9e-39]} {Mouse: ENSMUSG00000028266, Lmo4, LIM domain only 4, [Score=133, Expect=6e-39]} {Dmel: FBgn0032196, CG5708, [Score=120, Expect=4e-33]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=75.5, Expect=9e-16]} {Smed: dd_Smed_v6_27625_0_1, dd_Smed_v6_27625_0_1, [RH, Score=108, Expect=1e-28]} {RNA1509_53632} {RNA1310_25695, RNA1509_53632} {RNA1509_53632, RNA815_42113} |
53. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
2.709 | 0.846 | - | 0.887 | - | - | 0.976 | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
54. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
2.705 | 0.872 | - | 0.858 | - | - | 0.975 | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
55. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 2.703 | 0.835 | - | 0.885 | - | - | 0.983 | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
56. | MligTC455_50827 | 107 | 2.22 | Mlig455_037867 | Neo: - |
WSCD2 | 2.699 | 0.956 | 0.960 | - | 0.783 | - | - | Mlig455_037867 {REF} {Length: 912} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.4, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.9, Expect=4e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.9, Expect=2e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=46.2, Expect=8e-06]} {RNA1509_59284} {RNA1310_52794.1} {RNA815_21749.1} |
57. | MligTC455_03382 | 210 | 4.37 | Mlig455_057035 | Neo: - Age: - Region-enriched R2: 3.628/0.00113 |
PDE1C | 2.693 | 0.842 | - | 0.896 | - | - | 0.955 | Mlig455_057035 {REF} {Length: 2458} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=275.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=94.2]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [RH, Score=538, Expect=0.0]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=482, Expect=2e-164]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=613, Expect=0.0]} {RNA1509_46084} {RNA1310_8143.1} {RNA815_6002} |
58. | MligTC455_08911 | 45 | 0.94 | Mlig455_034546, Mlig455_064818 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.958/0.00652 |
2.693 | - | 0.884 | - | - | 0.832 | 0.977 | Mlig455_034546 {REF} {Length: 510} {RNA1310_82673} Mlig455_064818 {REF} {Length: 2324} {RNA1310_63036} |
|
59. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 2.687 | 0.964 | - | - | 0.787 | - | 0.936 | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
60. | MligTC455_40905 | 53 | 1.1 | Mlig455_002794, Mlig455_002809 | Neo: - Age: - |
CHL1 | 2.684 | 0.829 | - | 0.898 | - | - | 0.957 | Mlig455_002794 {REF} {Length: 4845} {Pfam: Immunoglobulin domain [PF13927.8, score=205.6]; Immunoglobulin I-set domain [PF07679.18, score=151.2]; Immunoglobulin domain [PF00047.27, score=122.8]; Immunoglobulin domain [PF13895.8, score=109.6]; Fibronectin type III domain [PF00041.23, score=98.8]; Immunoglobulin V-set domain [PF07686.19, score=65.4]; Immunoglobulin domain [PF18452.3, score=21.7]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [RH, Score=340, Expect=1e-96]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [RH, Score=339, Expect=2e-96]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [RH, Score=335, Expect=4e-95]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=358, Expect=2e-103]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=287, Expect=1e-79]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=486, Expect=3e-148]} {RNA1310_42673} Mlig455_002809 {REF} {Length: 4785} {Pfam: Immunoglobulin domain [PF13927.8, score=155.8]; Immunoglobulin I-set domain [PF07679.18, score=111.7]; Fibronectin type III domain [PF00041.23, score=99.0]; Immunoglobulin domain [PF00047.27, score=90.9]; Immunoglobulin domain [PF13895.8, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=38.0]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [Score=292, Expect=8e-81]; ENSG00000163531, NFASC, neurofascin, [Score=290, Expect=4e-80]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [Score=294, Expect=2e-81]; ENSMUSG00000026442, Nfasc, neurofascin, [Score=290, Expect=2e-80]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [Score=285, Expect=2e-78]; ENSMUSG00000020598, Nrcam, neuronal cell adhesion molecule, [Score=282, Expect=7e-78]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=315, Expect=1e-88]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=251, Expect=9e-68]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=441, Expect=4e-132]} {RNA1310_42673} |
61. | MligTC455_34693 | 336 | 7 | Mlig455_017459 | Neo: - Age: - Region-enriched R2: 6.024/0.00000 |
FZD4 | 2.683 | 0.875 | 0.953 | - | 0.855 | - | - | Mlig455_017459 {REF} {Length: 3882} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=335.8]; Fz domain [PF01392.24, score=90.0]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=424, Expect=3e-141]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=423, Expect=3e-141]} {Dmel: FBgn0001085, fz, frizzled, [Score=306, Expect=2e-95]} {Celegans: WBGene00003006, lin-17, Transmembrane receptor LIN-17, [RH, Score=271, Expect=1e-82]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=473, Expect=3e-160]} {RNA1509_10294} {RNA1310_2672} {RNA815_3209} |
62. | MligTC455_22098 | 31 | 0.66 | Mlig455_004396, Mlig455_037219 | Neo: - Age: - |
2.682 | - | - | 0.894 | 0.811 | - | 0.977 | Mlig455_004396 {REF} {Length: 1521} {RNA1310_40784} Mlig455_037219 {REF} {Length: 1583} {RNA1310_63625} |
|
63. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 2.673 | - | - | 0.899 | 0.797 | - | 0.977 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
64. | MligTC455_17778 | 198 | 4.12 | Mlig455_021327 | Neo: - Age: - |
2.666 | 0.893 | - | 0.820 | - | - | 0.953 | Mlig455_021327 {REF} {Length: 416} {TRANSSPLICED} {RNA1509_23323} {RNA1310_114939} | |
65. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.665 | 0.869 | - | 0.837 | - | - | 0.959 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
66. | MligTC455_43322 | 67 | 1.4 | Mlig455_032888 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.946 Region-enriched R2: 7.587/0.00001 |
2.664 | 0.742 | - | - | - | 0.970 | 0.952 | Mlig455_032888 {REF} {Length: 2179} {RNA1509_40507, RNA1509_49821} {RNA1310_22780, RNA1509_40507} {RNA1509_40507, RNA815_9762} | |
67. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 2.663 | - | - | 0.777 | 0.914 | - | 0.972 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
68. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 2.658 | 0.795 | - | 0.891 | - | - | 0.972 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
69. | MligTC455_51231 | 248 | 5.17 | Mlig455_010667, Mlig455_010763 | Neo: - Age: Down-Up-Down Region-specific R2: 4.726 Region-enriched R2: 3.928/0.00145 |
PRKX | 2.653 | - | 0.957 | - | 0.914 | 0.782 | - | Mlig455_010667 {REF} {Length: 1555} {RNA1509_52673} {RNA1310_54291, RNA1509_52673} {RNA1509_52673, RNA815_27753} Mlig455_010763 {REF} {Length: 1548} {Pfam: Protein kinase domain [PF00069.27, score=60.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=24.8]} {Human: ENSG00000183943, PRKX, protein kinase X-linked, [Score=174, Expect=1e-53]} {Mouse: ENSMUSG00000035725, Prkx, protein kinase, X-linked, [Score=176, Expect=8e-55]} {Dmel: FBgn0000489, Pka-C3, Protein kinase, cAMP-dependent, catalytic subunit 3, [Score=200, Expect=7e-62]} {Celegans: WBGene00002189, kin-1, cAMP-dependent protein kinase catalytic subunit, [Score=143, Expect=3e-42]} {Smed: dd_Smed_v6_3838_0_1, dd_Smed_v6_3838_0_1, [Score=231, Expect=6e-77]} {RNA1509_42883} {RNA1310_17167} {RNA815_27753} |
70. | MligTC455_46691 | 41 | 0.85 | Mlig455_018781, Mlig455_018951 | Neo: - Age: Up-Down-Down |
2.65 | - | 0.889 | 0.791 | - | - | 0.970 | Mlig455_018781 {REF} {Length: 1694} {Celegans: WBGene00021142, clec-133, C-type LECtin, [RH, Score=52.0, Expect=6e-08]} {RNA1310_43489} {RNA815_41340} Mlig455_018951 {REF} {Length: 2466} {Celegans: WBGene00021142, clec-133, C-type LECtin, [RH, Score=52.0, Expect=6e-08]} {RNA1310_38733.1} {RNA815_41340} |
|
71. | MligTC455_35259 | 2265 | 47.19 | Mlig455_040978 | Neo: - Age: Up-Down-Down Region-specific R2: 2.606 Region-enriched R2: 1.588/0.00387 |
ADGRL2 | 2.639 | - | 0.883 | - | 0.777 | - | 0.979 | Mlig455_040978 {REF} {Length: 10808} {TRANSSPLICED} {Pfam: PDZ domain [PF00595.26, score=86.9]; 7 transmembrane receptor (Secretin family) [PF00002.26, score=76.2]; PDZ domain [PF17820.3, score=67.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=52.3]; PDZ domain [PF13180.8, score=36.4]; ZU5 domain [PF00791.22, score=30.8]; Guanylate kinase [PF00625.23, score=22.4]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=174, Expect=1e-42]} {Mouse: ENSMUSG00000034917, Tjp3, tight junction protein 3, [RH, Score=172, Expect=9e-43]} {Dmel: FBgn0262614, pyd, polychaetoid, [RH, Score=232, Expect=8e-61]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=174, Expect=4e-43]} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [RH, Score=833, Expect=0.0]} {RNA1509_17602, RNA1509_52679, RNA1509_58629} {RNA1310_236.2, RNA1509_17602, RNA1509_58629} {RNA1509_17602, RNA1509_58629, RNA815_77.1} |
72. | MligTC455_41628 | 140 | 2.91 | Mlig455_015910 | Neo: - Age: - |
RYK | 2.63 | 0.873 | 0.956 | - | 0.801 | - | - | Mlig455_015910 {REF} {Length: 2784} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=111.2]; WIF domain [PF02019.20, score=98.1]; Protein kinase domain [PF00069.27, score=37.2]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.3]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=135, Expect=3e-33]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=136, Expect=2e-33]} {Dmel: FBgn0033791, Drl-2, Derailed 2, [Score=195, Expect=2e-53]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=116, Expect=4e-27]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=135, Expect=3e-33]} {RNA1310_8002.1} {RNA815_18265} |
73. | MligTC455_39957 | 170 | 3.54 | Mlig455_039809 | Neo: - Age: - Region-specific R2: 4.733 Region-enriched R2: 5.232/0.00000 |
ADGB | 2.622 | - | 0.871 | 0.796 | - | - | 0.955 | Mlig455_039809 {REF} {Length: 7010} {tRNA: Ile(TAT),pseudo, score=33.4} {Pfam: Calpain family cysteine protease [PF00648.23, score=34.1]} {Human: ENSG00000118492, ADGB, androglobin, [Score=403, Expect=6e-115]} {Mouse: ENSMUSG00000050994, Adgb, androglobin, [Score=252, Expect=4e-67]} {Celegans: WBGene00000543, clp-2, CaLPain family, [Score=73.2, Expect=1e-12]} {Smed: dd_Smed_v6_10677_0_1, dd_Smed_v6_10677_0_1, [Score=253, Expect=8e-68]} {RNA1509_15950, RNA1509_59203} {RNA1310_4821, RNA1509_59203} {RNA1509_59203, RNA815_12506} |
74. | MligTC455_41035 | 366 | 7.62 | Mlig455_000866 | Neo: - Age: logFC(26M/2M)=-0.773 Region-specific R2: 5.029 Region-enriched R2: 4.768/0.00000 |
2.621 | - | - | 0.871 | - | 0.763 | 0.987 | Mlig455_000866 {REF} {Length: 1126} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.6]} {RNA1509_27581} {RNA1310_74103, RNA1509_27581} {RNA1509_27581, RNA815_38377} | |
75. | MligTC455_40118 | 72 | 1.5 | Mlig455_001236 | Neo: - Age: - |
KCNIP4 | 2.62 | - | - | 0.914 | 0.722 | - | 0.984 | Mlig455_001236 {REF} {Length: 1284} {Pfam: EF-hand domain pair [PF13499.8, score=42.4]; EF hand [PF00036.34, score=38.6]; EF-hand domain [PF13405.8, score=33.5]; EF hand [PF13202.8, score=31.2]; EF-hand domain pair [PF13833.8, score=28.7]} {Human: ENSG00000185774, KCNIP4, potassium voltage-gated channel interacting protein 4, [Score=122, Expect=2e-32]; ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=122, Expect=2e-32]; ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=119, Expect=1e-30]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=124, Expect=5e-33]; ENSMUSG00000029088, Kcnip4, Kv channel interacting protein 4, [Score=122, Expect=1e-32]} {Dmel: FBgn0013303, Nca, Neurocalcin, [Score=100, Expect=6e-25]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=103, Expect=5e-26]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=122, Expect=8e-33]} {RNA1310_43225} {RNA815_33406} |
76. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.617 | 0.730 | - | 0.904 | - | - | 0.983 | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
77. | MligTC455_51432 | 21 | 0.43 | Mlig455_006079, Mlig455_068043 | Neo: - Age: - Region-enriched R2: 7.562/0.00199 |
2.616 | 0.869 | - | - | - | 0.791 | 0.956 | Mlig455_006079 {REF} {Length: 983} {Pfam: F5/8 type C domain [PF00754.27, score=24.7]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=57.8, Expect=9e-11]} {RNA1509_36923} {RNA1310_38503} {RNA815_10591.2} Mlig455_068043 {REF} {Length: 1040} {Pfam: F5/8 type C domain [PF00754.27, score=29.3]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=61.2, Expect=5e-12]} {RNA1509_36923} {RNA1310_38503} {RNA815_10591.2} |
|
78. | MligTC455_49855 | 19 | 0.39 | Mlig455_020555, Mlig455_020604 | Neo: - Age: - |
2.612 | - | - | 0.711 | 0.924 | - | 0.977 | Mlig455_020555 {REF} {Length: 1515} {RNA1509_44515} {RNA1310_26152} {RNA815_8882} Mlig455_020604 {REF} {Length: 370} {Pfam: PAN domain [PF00024.28, score=19.8]} {RNA1509_44515} {RNA1310_26152} {RNA815_8882} |
|
79. | MligTC455_14516 | 344 | 7.17 | Mlig455_006080, Mlig455_068033 | Neo: - Age: - Region-enriched R2: 2.671/0.04041 |
2.608 | - | 0.965 | 0.737 | 0.906 | - | - | Mlig455_006080 {REF} {Length: 1977} {RNA1509_31100} {RNA1310_11196} {RNA815_24298} Mlig455_068033 {REF} {Length: 2488} {RNA1509_31100} {RNA1310_11196, RNA1509_31100} {RNA1509_31100, RNA815_24298} |
|
80. | MligTC455_34925 | 183 | 3.82 | Mlig455_012715 | Neo: - Age: - |
CDKL1 | 2.599 | - | - | 0.746 | 0.890 | - | 0.963 | Mlig455_012715 {REF} {Length: 2370} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=250.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=120.6]; RIO1 family [PF01163.24, score=23.0]; ABC1 atypical kinase-like domain [PF03109.18, score=20.8]; Haspin like kinase domain [PF12330.10, score=20.4]; Kinase-like [PF14531.8, score=19.4]} {Human: ENSG00000100490, CDKL1, cyclin dependent kinase like 1, [RH, Score=437, Expect=3e-153]; ENSG00000205111, CDKL4, cyclin dependent kinase like 4, [RH, Score=424, Expect=2e-147]} {Mouse: ENSMUSG00000020990, Cdkl1, cyclin-dependent kinase-like 1 (CDC2-related kinase), [RH, Score=437, Expect=2e-153]; ENSMUSG00000033966, Cdkl4, cyclin-dependent kinase-like 4, [RH, Score=432, Expect=2e-151]} {Dmel: FBgn0031730, CG7236, [RH, Score=384, Expect=3e-131]} {Celegans: WBGene00012779, cdkl-1, Cyclin-Dependent Kinase-Like, [RH, Score=388, Expect=3e-132]} {Smed: dd_Smed_v6_9353_0_1, dd_Smed_v6_9353_0_1, [RH, Score=472, Expect=5e-167]} {RNA1509_44617} {RNA1310_15038, RNA1509_44617} {RNA1509_44617, RNA815_6379} |
81. | MligTC455_29010 | 388 | 8.08 | Mlig455_038247 | Neo: - Age: logFC(26M/2M)=0.983 |
2.596 | - | 0.957 | - | 0.869 | - | 0.770 | Mlig455_038247 {REF} {Length: 4647} {RNA1509_26411} {RNA1310_63.1} {RNA815_23.1} | |
82. | MligTC455_32445 | 285 | 5.93 | Mlig455_041727, Mlig455_042282 | Neo: - Age: - |
ANK2 | 2.589 | 0.901 | - | - | 0.719 | - | 0.969 | Mlig455_041727 {REF} {Length: 4931} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.7]; Ankyrin repeats (many copies) [PF13637.8, score=238.3]; Ankyrin repeat [PF00023.32, score=223.0]; Ankyrin repeats (many copies) [PF13857.8, score=214.9]; Ankyrin repeat [PF13606.8, score=201.4]; Ion transport protein [PF00520.33, score=46.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=211, Expect=1e-54]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=290, Expect=2e-80]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=210, Expect=2e-54]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=489, Expect=7e-151]} {Smed: dd_Smed_v6_6201_0_2, dd_Smed_v6_6201_0_2, [RH, Score=745, Expect=0.0]} {RNA1509_18945} {RNA1310_1506.1, RNA1509_18945} {RNA1509_18945, RNA815_450.1} Mlig455_042282 {REF} {Length: 4940} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=273.8]; Ankyrin repeats (many copies) [PF13637.8, score=232.4]; Ankyrin repeat [PF00023.32, score=218.4]; Ankyrin repeats (many copies) [PF13857.8, score=210.6]; Ankyrin repeat [PF13606.8, score=197.5]; Ion transport protein [PF00520.33, score=46.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=214, Expect=2e-55]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=204, Expect=1e-52]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=201, Expect=2e-51]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=205, Expect=6e-53]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=487, Expect=5e-150]} {Smed: dd_Smed_v6_6201_0_2, dd_Smed_v6_6201_0_2, [RH, Score=736, Expect=0.0]} {RNA1509_18945} {RNA1310_1506.1} {RNA815_8298} |
83. | MligTC455_45909 | 21 | 0.43 | Mlig455_048634, Mlig455_068858 | Neo: - Age: - |
ANGPT4 | 2.583 | - | - | 0.783 | 0.834 | - | 0.966 | Mlig455_048634 {REF} {Length: 490} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=169.7]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=134, Expect=3e-35]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=127, Expect=3e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=126, Expect=1e-32]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=124, Expect=6e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=123, Expect=8e-32]; ENSMUSG00000033327, Tnxb, tenascin XB, [Score=122, Expect=1e-30]; ENSMUSG00000031465, Angpt2, angiopoietin 2, [Score=122, Expect=3e-31]} {Dmel: FBgn0087011, CG41520, [Score=108, Expect=3e-26]} {Celegans: WBGene00020516, T15B7.1, [Score=66.2, Expect=3e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=121, Expect=5e-31]} {RNA1310_35640.1} Mlig455_068858 {REF} {Length: 1227} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=169.7]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=134, Expect=3e-35]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=127, Expect=3e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=126, Expect=1e-32]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=124, Expect=6e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=123, Expect=8e-32]; ENSMUSG00000033327, Tnxb, tenascin XB, [Score=122, Expect=1e-30]; ENSMUSG00000031465, Angpt2, angiopoietin 2, [Score=122, Expect=3e-31]} {Dmel: FBgn0087011, CG41520, [Score=108, Expect=3e-26]} {Celegans: WBGene00020516, T15B7.1, [Score=66.2, Expect=3e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=121, Expect=5e-31]} {RNA1310_35640.1} {RNA815_23388} |
84. | MligTC455_35529 | 117 | 2.43 | Mlig455_020107, Mlig455_069888 | Neo: - Age: - |
2.576 | 0.887 | - | - | 0.736 | - | 0.953 | Mlig455_020107 {REF} {Length: 3566} {RNA1509_53783} {RNA1310_29335.1} {RNA815_9084.1} Mlig455_069888 {REF} {Length: 2216} {RNA1509_44264} {RNA1310_56703} {RNA815_9084.1} |
|
85. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
2.571 | 0.785 | - | 0.809 | - | - | 0.977 | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
86. | MligTC455_48848 | 282 | 5.87 | Mlig455_005151, Mlig455_021613 | Neo: - Age: - Region-specific R2: 4.764 Region-enriched R2: 5.813/0.00000 |
SYT3 | 2.566 | - | - | 0.883 | 0.730 | - | 0.953 | Mlig455_005151 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} Mlig455_021613 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} |
87. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 2.563 | 0.830 | - | 0.777 | - | - | 0.956 | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
88. | MligTC455_29568 | 176 | 3.66 | Mlig455_017614 | Neo: - |
ANK3 | 2.559 | - | - | 0.847 | - | 0.750 | 0.962 | Mlig455_017614 {REF} {Length: 6338} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=263.9]; Ankyrin repeats (many copies) [PF13637.8, score=213.4]; Ankyrin repeats (many copies) [PF13857.8, score=202.3]; Ankyrin repeat [PF00023.32, score=187.3]; Ankyrin repeat [PF13606.8, score=162.7]; Mab-21 protein [PF03281.16, score=40.8]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=261, Expect=8e-70]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=261, Expect=4e-70]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=245, Expect=2e-65]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=228, Expect=4e-60]} {Smed: dd_Smed_v6_3523_0_1, dd_Smed_v6_3523_0_1, [Score=229, Expect=1e-60]} {RNA1509_28853, RNA1509_40339, RNA1509_51832} {RNA1310_6164, RNA1509_28853, RNA1509_40339, RNA1509_51832} {RNA1509_28853, RNA1509_40339, RNA1509_51832, RNA815_1489.1} |
89. | MligTC455_42839 | 29 | 0.61 | Mlig455_003852 | Neo: - Age: - |
2.557 | - | - | 0.732 | - | 0.848 | 0.977 | Mlig455_003852 {REF} {Length: 1047} {RNA1509_48973} {RNA1310_36721} {RNA815_36286} | |
90. | MligTC455_13259 | 11 | 0.23 | Mlig455_026238, Mlig455_042504 | Neo: - Age: - |
KREMEN1 | 2.55 | - | 0.952 | 0.843 | 0.755 | - | - | Mlig455_026238 {REF} {Length: 468} Mlig455_042504 {REF} {Length: 806} {Pfam: WSC domain [PF01822.21, score=46.2]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=51.6, Expect=3e-07]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=49.3, Expect=9e-07]} {RNA1310_57841} {RNA815_19006.2} |
91. | MligTC455_35417 | 539 | 11.23 | Mlig455_025920, Mlig455_025952 | Neo: - Age: - Region-enriched R2: 3.849/0.00283 |
2.544 | 0.723 | 0.962 | - | 0.859 | - | - | Mlig455_025920 {REF} {Length: 3607} {RNA1509_50554, RNA1509_8462} {RNA1310_23985, RNA1509_50554} {RNA1509_50554, RNA815_9218.1} Mlig455_025952 {REF} {Length: 3531} {RNA1509_48873, RNA1509_8462} {RNA1310_23985, RNA1509_48873} {RNA1509_48873, RNA815_9218.1} |
|
92. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
2.543 | - | - | 0.856 | 0.724 | - | 0.963 | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
93. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
2.542 | 0.823 | 0.965 | - | 0.754 | - | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
94. | MligTC455_47975 | 31 | 0.64 | Mlig455_018682, Mlig455_043427 | Neo: - Age: Up-Down-Down |
ISL1 | 2.541 | 0.877 | - | 0.713 | - | - | 0.951 | Mlig455_018682 {REF} {Length: 3387} {Pfam: LIM domain [PF00412.24, score=95.5]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.7]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=202, Expect=6e-60]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=202, Expect=4e-60]} {Dmel: FBgn0003896, tup, tailup, [RH, Score=178, Expect=3e-49]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [RH, Score=228, Expect=5e-69]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=320, Expect=1e-103]} {RNA1310_20628} {RNA815_37694} Mlig455_043427 {REF} {Length: 3365} {Pfam: LIM domain [PF00412.24, score=77.4]; Homeodomain [PF00046.31, score=53.3]; Homeobox KN domain [PF05920.13, score=21.8]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=167, Expect=2e-46]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=167, Expect=1e-46]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=160, Expect=4e-44]} {Dmel: FBgn0003896, tup, tailup, [Score=144, Expect=1e-37]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=204, Expect=6e-60]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=274, Expect=7e-86]} {RNA1310_20628} {RNA815_37694} |
95. | MligTC455_48827 | 761 | 15.86 | Mlig455_042518 | Neo: - Age: logFC(26M/2M)=-0.412 |
ANO7 | 2.537 | - | - | 0.836 | 0.745 | - | 0.956 | Mlig455_042518 {REF} {Length: 4110} {Pfam: Calcium-activated chloride channel [PF04547.14, score=290.9]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=33.9]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=164, Expect=8e-41]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=165, Expect=1e-41]; ENSMUSG00000031075, Ano1, anoctamin 1, calcium activated chloride channel, [Score=160, Expect=1e-39]; ENSMUSG00000064210, Ano6, anoctamin 6, [Score=157, Expect=4e-39]} {Dmel: FBgn0030349, CG10353, [Score=157, Expect=6e-39]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=263, Expect=3e-75]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=161, Expect=5e-41]} {RNA1509_6346} {RNA1310_5254, RNA1509_6346} {RNA1509_6346, RNA815_4443} |
96. | MligTC455_26766 | 638 | 13.3 | Mlig455_017977 | Neo: - Age: Up-Down-Down Region-specific R2: 4.360 Region-enriched R2: 3.395/0.00052 |
2.535 | - | 0.722 | 0.835 | - | - | 0.978 | Mlig455_017977 {REF} {Length: 2516} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [Score=249, Expect=3e-71]} {RNA1509_19813} {RNA1310_621} {RNA815_183.1} | |
97. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
2.533 | - | - | 0.827 | 0.729 | - | 0.977 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
98. | MligTC455_40353 | 39 | 0.82 | Mlig455_024525 | Neo: - Age: - |
2.531 | - | - | 0.764 | 0.806 | - | 0.961 | Mlig455_024525 {REF} {Length: 1158} {RNA1310_29008} | |
99. | MligTC455_18161 | 771 | 16.05 | Mlig455_031626, Mlig455_048205 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.318/0.00160 |
2.529 | 0.792 | 0.952 | - | 0.785 | - | - | Mlig455_031626 {REF} {Length: 835} {TRANSSPLICED} {RNA1509_48514} {RNA1310_56583, RNA1509_48514} {RNA1509_48514, RNA815_34758} Mlig455_048205 {REF} {Length: 651} {RNA1509_48514} {RNA1310_56583} {RNA815_34758} |
|
100. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
2.528 | 0.809 | 0.965 | - | 0.754 | - | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} |